Boston Scientific

Boston Scientific
VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Boston Scientific is a leading innovator of medical solutions that improve the health of patients around the world. With 24,000 employees worldwide, sales force in 40+ countries, and 15 manufacturing facilities worldwide, the company invested $895 million in R&D in 2011, with a $7.6 billion revenue.  Continue reading «Boston Scientific»

Website Share Login to Edit

Full Description

Boston Scientific is a leading innovator of medical solutions that improve the health of patients around the world. With 24,000 employees worldwide, sales force in 40+ countries, and 15 manufacturing facilities worldwide, the company invested $895 million in R&D in 2011, with a $7.6 billion revenue.

 

rel="nofollow"

Address

Boston Scientific Corporate Headquarters One Boston Scientific Place Natick, MA 01760-1537, USA

Phone

+1 (508) 650-8000

Twitter username

https://twitter.com/bostonsci


Company News

  • Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation

    Delaware Court Rules Edwards Lifesciences Infringes Boston Scientific Patent MARLBOROUGH, Mass., Dec. 11, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that a jury in the United States (U.S.) District Court for the District of Delaware determined that the Boston Scientific U.S. patent 8,992,608 is valid and that Edwards Lifesciences' Sapien 3™ Aortic Valve infringes this patent and that Edwards owes Boston Scientific infringement damages through the end of 2016. Additional damages and interest incurred from 2017-2018 will be determined by the court in post-trial motions. The jury also found that the Boston Scientific LOTUS™ Aortic Valve System does not ...
  • Boston Scientific to Participate in 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference

    MARLBOROUGH, Mass., Dec. 3, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018 in New York City. Susie Lisa, vice president, Investor Relations and Lindsay Fish, director, Investor Relations, will participate in a 35-minute question-and-answer session with the host analyst beginning at approximately 11:20 a.m. EST.  A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. A replay of the webcast will be accessible at investors.bostonscientif...
  • Boston Scientific to Participate in Citi's 2018 Global Healthcare Conference

    MARLBOROUGH, Mass., Nov. 27, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York City. Art Butcher, senior vice president and president, Endoscopy and Susie Lisa, vice president, Investor Relations, will participate in a 40-minute question-and-answer session with the host analyst beginning at approximately 9:30 a.m. EST.  A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. A replay of the webcast will be accessible at investors.b...
  • Boston Scientific to Participate in the 30th Annual Piper Jaffray Healthcare Conference

    MARLBOROUGH, Mass., Nov. 21, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 30th Annual Piper Jaffray Healthcare Conference on Thursday, November 29, 2018 in New York City. Jeff Mirviss, senior vice president and president, Peripheral Interventions and Susie Lisa, vice president, Investor Relations will participate in a 25-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EST. A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. A replay of the webcast will be...
  • Boston Scientific Announces Recommended Offer to Acquire BTG plc.

    Transaction would expand peripheral interventions portfolio with minimally-invasive treatments for cancers and vascular conditions MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc. (LSE: BTG), a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals.  The transaction has been unanimously approved by the boards of directors of Boston Scientific and BTG. Under the terms of the transaction, holders of BTG's common ...
  • Boston Scientific to Participate in 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

    MARLBOROUGH, Mass., Nov. 7, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City. David Pierce, executive vice president and president, MedSurg and Susie Lisa, vice president, Investor Relations, will participate in a 60-minute roundtable discussion session with the host analyst beginning at approximately 9:30 a.m. EST.  A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. A replay of the webcast will be accessible at investors.bostonscientific.c...
  • Boston Scientific to Participate in Stifel 2018 Healthcare Conference

    MARLBOROUGH, Mass., Nov. 6, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 in New York City. Dan Brennan, executive vice president and chief financial officer and Susie Lisa, vice president, Investor Relations, will participate in a 40-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EST.  A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. A replay of the webcast will be accessible at investors.bostonscientific.com beginning ...